Exchange: OTC·Updated 02:22 PM EDT

EVFM Evofem Biosciences Inc

$0.0082
$0.0007
(9.33%)
Today
Mkt Cap$993,976.00
Vol67,052.00

About EVFM

Evofem Biosciences, Inc. is a commercial-stage biopharmaceutical company, which develops and commercializes products to women's sexual and reproductive health. Its product includes Phexxi (lactic acid, citric acid and potassium bitartrate), a hormone-free vaginal gel and EVO100, an investigational drug, which is used for urogenital Chlamydia trachomatis and Neisseria gonorrhoeae infection in women. The company was founded in 2007 and is headquartered in San Diego, CA.
37

Bearish Sentiment

How do you feel about EVFM?

Advertisement|Remove ads.